Drug
AK120 clinical trials
Also written AK120.
Keep track of what changes. Save the AK120 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
- AK120
- 6
Studies by the year they started
7 studies that test it; most in 2024 (3)
| Year | Studies |
|---|---|
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 0
Studies
Open first, then newest update. How each study uses AK120 is read from its arms, and is right about nine times in ten.
Testing it · 7
- A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis (AD)Not yet recruitingPhase 2AkesoNCT06756126Written as AK120
- A Phase III Study to Evaluate the Efficacy and Safety of AK120 in Patients With Moderate to Severe Atopic DermatitisRecruitingPhase 3AkesoNCT06383468Written as AK120
- A Study to Evaluate the Efficacy and Safety of AK120 in Subjects With Moderate to Severe Atopic DermatitisCompletedPhase 2AkesoNCT06700499Written as AK120 300mg Q2W (JAK inhibitor users need to double the initial dose)
- A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of AK120 in Subjects With Atopic DermatitisCompletedPhase 1/2AkesoNCT06035354Written as AK120
- Phase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic DermatitisTerminatedPhase 2Akesobio Australia Pty LtdNCT05048056Written as AK120
- A Study to Evaluate the Safety and Efficacy of AK120 in Subjects With Moderate to Severe Atopic DermatitisCompletedPhase 2AkesoNCT06092762Written as AK120
- A Study to Evaluate the Efficacy and Safety of AK120 in the Treatment of Subjects With Moderate-to-severe AsthmaTerminatedPhase 2AkesoNCT05155020Written as AK120